Digital Pathology Market Overview:
Digital pathology is defined as an image-based information environment for the management, analysis, and the interpretation of the information achieved from a digital slide. In short, the digitalization of conventional pathology lab is referred to as digital pathology. This technology has gained momentum in the global medical and healthcare industry, owing to the improvements it brings in a number of application such as drug discoveries and their development, multi-functionalities in instruments, diagnostic tests, and other research applications.
Rise in cancer incidences, increasing teleconsultations, high efficiency of digital pathology systems, increased adoption rate, increasing government and industry player’s initiatives are paving the way for the overall growth of the digital pathology market globally. On the other hand, barriers such as stringent regulatory concerns for primary diagnosis, the nonexistence of standard guidelines for digital pathology, lack of reimbursement and skilled personnel are some of the major factors likely to restrain the market growth. However, rising need for integrated healthcare facilities which can be achieved through establishing digital pathology systems would offer profitable growth opportunities for the service providers in the future if they can overcome threats like the high cost of establishing new technology or infrastructure.
Digital Pathology Market Forecast Report (2019-2024)
Global Digital Pathology Market was worth USD 463.5 Million in 2019 and estimated to be growing at a CAGR of 11.66%, to reach USD 804.3 Million by 2024.
The Global Digital Pathology Market is thoroughly segmented by Type, Product, Application and End user. Further based on the type it is segmented into Human Digital Pathology and Animal Digital Pathology. While by Product it is categorized into Scanners, Software, Communication Systems and Storage Systems, based on Application it is segmented into Teleconsultation, Diseases Diagnosis, Drug Discovery and Training & Education categories. Finally, by End User, it is segmented into Pharmaceutical Companies, Hospitals, and Academic Institutions. While Scanners segment accounts for the largest market share in 2015, software segment is surely catching up to it growing fast paced with the development of technology.
On the other hand, based on geography it is segmented and analyzed under the regions of North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. While North America accounts for the largest share of the global digital pathology market closely followed by Europe the development is concentrated around the region of Asia-Pacific.
Key Developments in the Market
Some of the key players operating in the market include
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 Human Digital Pathology
5.1.2 Animal Digital Pathology
5.2 By Product
5.2.1 Scanners
5.2.2 Software
5.2.3 Communication Systems
5.2.4 Storage Systems
5.3 By Application
5.3.1 Teleconsultation
5.3.2 Disease Diagnosis
5.3.3 Drug Discovery
5.3.4 Training and Education
5.4 By End User
5.4.1 Pharmaceutical Companies
5.4.2 Hospitals
5.4.3 Academic Institutes
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 France
6.2.4 Germany
6.2.5 Italy
6.2.6 Spain
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1. Perkin Elmer, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2. Definiens AG
8.3. Sectra AB
8.4. Koninklijke Philips N.V
8.5. GE Healthcare
8.6. Inspirata Co.
8.7. Ventana Medical Systems, Inc.
8.8. Leica Biosystems
8.9. 3D-Histech Ltd
8.10. Hamamatsu Photonics, K.K.
8.11. Digipath Co.
8.12. ZEISS
8.13. Olympus Corporation
8.14. Yokogawa Electronic Corporation
8.15. Quorum Technologies Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
